DOJ Says Mallinckrodt Bilked Medicaid As Drug Price Soared

By Chris Villani (March 3, 2020, 4:35 PM EST) -- Mallinckrodt ARD Inc. shortchanged Medicaid by hundreds of millions of dollars as the company hiked the price of its drug H.P. Acthar Gel, the U.S. Department of Justice alleged in a False Claims Act suit unsealed Tuesday in Massachusetts.

Mallinckrodt and the company it bought in 2014 for $5.6 billion, Questcor Pharmaceuticals Inc., illegally underpaid rebates that were owed to the government as a result of the sharp price increase for Acthar, a gel used to treat a variety of conditions from multiple sclerosis to infantile spasms to kidney damage, the suit says. When Questcor acquired Acthar in 2001, the drug...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!